Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Eribulin mesylate for the treatment of patients with refractory metastatic breast cancer: use of a "physician's choice" control arm in a randomized approval trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 28, 2012
Showing 1-2 of 2
Last Updated: 09/26/2026